Federico Angriman, MD, MPH
- 3Articles
- 27.3KReads1
- 2017–2021Active
- 12Collaborators
- 37Citations2
About
Federico Angriman, MD, MPH, is affiliated with the Institute for Health Policy, Management and Evaluation at the Dalla Lana School of Public Health and the Department of Critical Care Medicine at Sunnybrook Health Sciences Centre, University of Toronto. His publications from 2017 to 2021 focus on the clinical implications of antipsychotic use in patients with schizophrenia, schizoaffective disorders, and anxiety, particularly examining associations with pulmonary disease, venous thromboembolic events, and cardiovascular outcomes. He has collaborated frequently with co-authors including Alejandro G. Szmulewicz and Augusto Ferraris.
Publications
Antipsychotics and Bacteremia in Adults With COPD
April 13, 2021
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
